Oral use of Swedish moist snuff (snus) and risk for cancer of the mouth, lung, and pancreas in male construction workers: a retrospective cohort study

Lancet

Volumn 369, Issue 9578, 2007, Pages 2015-2020

  Luo, Juhua ^a   Ye, Weimin ^a   Zendehdel, Kazem ^a,b   Adami, Johanna ^a   Adami, Hans Olov ^a,c   Boffetta, Paolo ^a,d   Nyrén, Olof ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER RISK; CONFIDENCE INTERVAL; CONSTRUCTION WORK; FOLLOW UP; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; PANCREAS CANCER; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SMOKELESS TOBACCO; SMOKING;

EID: 34250222462     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(07)60678-3     Document Type: Article

References (39)

1. Rodu B., Nasic S., and Cole P. Tobacco use among Swedish schoolchildren. Tob Control 14 (2005) 405-408
2. Stegmayr B., Eliasson M., and Rodu B. The decline of smoking in northern Sweden. Scand J Public Health 33 (2005) 321-324
3. Hoffmann D., Djordjevic M., Fan J., Zang E., Glynn T., and Connolly G. Five leading U.S. commercial brands of moist snuff in 1994: assessment of carcinogenic N-nitrosamines. J Natl Cancer Inst 87 (1995) 1862-1869
4. Hecht S. DNA adduct formation from tobacco-specific N-nitrosamines. Mutat Res 424 (1999) 127-142
5. Hoffmann D., and Djordjevic M. Chemical composition and carcinogenicity of smokeless tobacco. Adv Dent Res 11 (1997) 322-329
6. Hecht S. Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem Res Toxicol 11 (1998) 559-603
7. Rodu B., and Jansson C. Smokeless tobacco and oral cancer: a review of the risks and determinants. Crit Rev Oral Biol Med 15 (2004) 252-263
8. Lewin F., Norell S., Johansson H., et al. Smoking tobacco, oral snuff, and alcohol in the etiology of squamous cell carcinoma of the head and neck: a population-based case-referent study in Sweden. Cancer 82 (1998) 1367-1375
9. Bjelke E. Chew tobacco and use of snuff: relationship to cancer of the pancreas and other sites in two prospective studies. Proceedings of the 13th International Cancer Congress (1982) 207 (abstr).
10. Boffetta P., Aagnes B., Weiderpass E., and Andersen A. Smokeless tobacco use and risk of cancer of the pancreas and other organs. Int J Cancer 114 (2005) 992-995
11. Gupta P., and Ray C. Smokeless tobacco and health in India and South Asia. Respirology 8 (2003) 419-431
12. IARC Working Group. Tobacco habits other than smoking; betel-quid and areca-nut chewing; and some related nitrosamines. IARC Monogr Eval Carcinog Risk Chem Hum 37 (1985) 1-268
13. Cogliano V., Straif K., Baan R., Grosse Y., Secretan B., and El Ghissassi F. Smokeless tobacco and tobacco-related nitrosamines. Lancet Oncol 5 (2004) 708
14. Rivenson A., Hoffmann D., Prokopczyk B., Amin S., and Hecht S. Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and Areca-derived N-nitrosamines. Cancer Res 48 (1988) 6912-6917
15. Prokopczyk B., Rivenson A., and Hoffmann D. A study of betel quid carcinogenesis. IX. Comparative carcinogenicity of 3-(methylnitrosamino)propionitrile and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone upon local application to mouse skin and rat oral mucosa. Cancer Lett 60 (1991) 153-157
16. Alguacil J., and Silverman D. Smokeless and other noncigarette tobacco use and pancreatic cancer: a case-control study based on direct interviews. Cancer Epidemiol Biomarkers Prev 13 (2004) 55-58
17. Zheng W., McLaughlin J., Gridley G., et al. A cohort study of smoking, alcohol consumption, and dietary factors for pancreatic cancer (United States). Cancer Causes Control 4 (1993) 477-482
18. Muscat J., Stellman S., Hoffmann D., and Wynder E. Smoking and pancreatic cancer in men and women. Cancer Epidemiol Biomarkers Prev 6 (1997) 15-19
19. Rodu B., Stegmayr B., Nasic S., and Asplund K. Impact of smokeless tobacco use on smoking in northern Sweden. J Intern Med 252 (2002) 398-404
20. Ramström L. Reduction of smoking and smoking-related health hazards by promoting alternative nicotine delivery systems. UN Focal Point on Tobacco and Health (1997), ICAA and EMASH, Geneva
21. Nyren O., Bergstrom R., Nystrom L., et al. Smoking and colorectal cancer: a 20-year follow-up study of Swedish construction workers. J Natl Cancer Inst 88 (1996) 1302-1307
22. Mattsson B., and Wallgren A. Completeness of the Swedish Cancer Register. Non-notified cancer cases recorded on death certificates in 1978. Acta Radiol Oncol 23 (1984) 305-313
23. Ekstrom A., Signorello L., Hansson L., Bergstrom R., Lindgren A., and Nyren O. Evaluating gastric cancer misclassification: a potential explanation for the rise in cardia cancer incidence. J Natl Cancer Inst 91 (1999) 786-790
24. Lin D., Wei L., and Ying Z. Checking the Cox model with cumulative sums of martingale-based residuals. Biometrika 80 (1993) 557-572
25. Boffetta P., Aagnes B., Weiderpass E., and Andersen A. Response to comments by Drs. Rutqvist, Lewin, Nilsson, Ramstrom, Rodu and Cole further to the publication of the manuscript "smokeless tobacco use and risk of cancer of the pancreas and other organs". Int J Cancer 118 (2006) 1586-1587
26. Williams R., and Horm J. Association of cancer sites with tobacco and alcohol consumption and socioeconomic status of patients: interview study from the Third National Cancer Survey. J Natl Cancer Inst 58 (1977) 525-547
27. Farrow D., and Davis S. Risk of pancreatic cancer in relation to medical history and the use of tobacco, alcohol and coffee. Int J Cancer 45 (1990) 816-820
28. Gilljam H., and Galanti M. Role of snus (oral moist snuff) in smoking cessation and smoking reduction in Sweden. Addiction 98 (2003) 1183-1189
29. Prokopczyk B., Hoffmann D., Bologna M., et al. Identification of tobacco-derived compounds in human pancreatic juice. Chem Res Toxicol 15 (2002) 677-685
30. Schuller H. Mechanisms of smoking-related lung and pancreatic adenocarcinoma development. Nat Rev Cancer 2 (2002) 455-463
31. Persson P., Carlsson S., Svanstrom L., Ostenson C., Efendic S., and Grill V. Cigarette smoking, oral moist snuff use and glucose intolerance. J Intern Med 248 (2000) 103-110
32. Gapstur S., Gann P., Lowe W., Liu K., Colangelo L., and Dyer A. Abnormal glucose metabolism and pancreatic cancer mortality. Jama 283 (2000) 2552-2558
33. Rosenquist K., Wennerberg J., Schildt E., Bladstrom A., Hansson B., and Andersson G. Use of Swedish moist snuff, smoking and alcohol consumption in the aetiology of oral and oropharyngeal squamous cell carcinoma. A population-based case-control study in southern Sweden. Acta Otolaryngol 125 (2005) 991-998
34. Schildt E., Eriksson M., Hardell L., and Magnuson A. Oral snuff, smoking habits and alcohol consumption in relation to oral cancer in a Swedish case-control study. Int J Cancer 77 (1998) 341-346
35. Henley S., Thun M., Connell C., and Calle E. Two large prospective studies of mortality among men who use snuff or chewing tobacco (United States). Cancer Causes Control 16 (2005) 347-358
36. Accortt N., Waterbor J., Beall C., and Howard G. Cancer incidence among a cohort of smokeless tobacco users (United States). Cancer Causes Control 16 (2005) 1107-1115
37. Schneeweiss S. Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics. Pharmacoepidemiol Drug Saf 15 (2006) 291-303
38. Furberg H., Lichtenstein P., Pedersen N., Bulik C., and Sullivan P. Cigarettes and oral snuff use in Sweden: prevalence and transitions. Addiction 101 (2006) 1509-1515
39. Ekbom A., and Hunter D. Pancreatic cancer. In: Adami H., Hunter D., and Trichopoulos D. (Eds). Textbook of cancer epidemiology (2002), Oxford University Press, New York 233-247